Sivik Global Healthcare LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Sivik Global Healthcare LLC disclosed 36 US equity positions worth $180.8m in its Q4 2024 13F filing. The largest position was XBI at 10.0% of the reported book, followed by LLY and BSX. Against the Q3 2024 filing, it opened 12 new positions, added to 6 and reduced 16 among the top 36 holdings.
What did Sivik Global Healthcare LLC own in Q4 2024? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 10.0% | $18.0m | 200,000 | -33% | reduced | |
| 2 | LLY ELI LILLY & CO | Healthcare | 6.4% | $11.6m | 15,000 | 3% | added |
| 3 | BSX BOSTON SCIENTIFIC CORPORATION | Healthcare | 5.4% | $9.8m | 110,000 | 5% | added |
| 4 | MCK MCKESSON CORP | Healthcare | 4.7% | $8.5m | 15,000 | -25% | reduced |
| 5 | SYK STRYKER CORP | Healthcare | 4.0% | $7.2m | 20,000 | -26% | reduced |
| 6 | THC TENET HEALTHCARE | Healthcare | 3.8% | $6.9m | 55,000 | -15% | reduced |
| 7 | UHS UNIV HEALTH SVC | Healthcare | 3.7% | $6.7m | 37,500 | -17% | reduced |
| 8 | UNH UNITEDHEALTH GRP | Healthcare | 3.5% | $6.3m | 12,500 | – | new |
| 9 | NVO NOVO-NORDISK A/S | Healthcare | 3.3% | $6.0m | 70,000 | -22% | reduced |
| 10 | HCA HCA HEALTHCARE INC | Healthcare | 3.3% | $6.0m | 20,000 | 0% | held |
| 11 | CAH CARDINAL HEALTH | Healthcare | 3.3% | $5.9m | 50,000 | 11% | added |
| 12 | DHR DANAHER CORP | Healthcare | 3.2% | $5.7m | 25,000 | -17% | reduced |
| 13 | ABT ABBOTT LABS | Healthcare | 3.1% | $5.7m | 50,000 | -17% | reduced |
| 14 | COR CENCORA INC | Healthcare | 3.1% | $5.6m | 25,000 | 0% | held |
| 15 | VRTX VERTEX PHARMACEUTICALS INC. | Healthcare | 2.9% | $5.2m | 13,000 | 30% | added |
| 16 | WAT WATERS CORP | Healthcare | 2.9% | $5.2m | 14,000 | – | new |
| 17 | HUM HUMANA INC. | Healthcare | 2.8% | $5.1m | 20,000 | 100% | added |
| 18 | A AGILENT TECHNOLOGIES INC | Healthcare | 2.6% | $4.7m | 35,000 | – | new |
| 19 | ABBV ABBVIE INC | Healthcare | 2.5% | $4.4m | 25,000 | – | new |
| 20 | SGRY SURGERY PARTNERS INC | Healthcare | 2.3% | $4.2m | 200,000 | -13% | reduced |
| 21 | AVTR AVANTOR INC | Healthcare | 2.3% | $4.2m | 200,000 | -20% | reduced |
| 22 | EHC ENCOMPASS HEALTH CORP | Healthcare | 2.3% | $4.2m | 45,000 | -10% | reduced |
| 23 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 2.2% | $4.0m | 70,000 | – | new |
| 24 | EW EDWARDS LIFESCIENCES | Healthcare | 2.0% | $3.7m | 50,000 | – | new |
| 25 | CI CIGNA GROUP/THE | Healthcare | 1.8% | $3.3m | 12,000 | – | new |
| 26 | BIO BIO-RAD LABS A | Healthcare | 1.8% | $3.3m | 10,000 | – | new |
| 27 | SNN SMITH & NEPHEW | Healthcare | 1.7% | $3.1m | 125,000 | -11% | reduced |
| 28 | SELECT MEDICAL HOLDINGS CORP | 1.6% | $2.8m | 150,000 | 7% | added | |
| 29 | ZTS ZOETIS INC | Healthcare | 1.4% | $2.4m | 15,000 | – | new |
| 30 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 1.2% | $2.1m | 20,000 | -50% | reduced |
| 31 | ACHC ACADIA HEALTHCRE | Healthcare | 1.1% | $2.0m | 50,000 | -57% | reduced |
| 32 | BNTX BIONTECH SE | Healthcare | 0.9% | $1.7m | 15,000 | – | new |
| 33 | ALNY ALNYLAM PHARMACEUTICALS | Healthcare | 0.9% | $1.6m | 7,000 | – | new |
| 34 | RGEN REPLIGEN CORP | Healthcare | 0.8% | $1.4m | 10,000 | -60% | reduced |
| 35 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 0.7% | $1.2m | 10,000 | – | new |
| 36 | MRVI MARAVAI LIFESCIENCES HLDGS-A | Healthcare | 0.4% | $763.0k | 140,000 | -67% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.